Jerold Chun, MD, PhD, is Professor and Senior Vice President of Neuroscience Drug Discovery at Sanford Burnham Prebys Medical Discovery Institute (SBP). He received his MD and PhD degrees (Neuroscience; with C.J. Shatz) through the Medical Scientist Training Program at Stanford University School of Medicine. He moved east as a Helen Hay Whitney Postdoctoral Fellow to the Whitehead Institute for Biomedical Research, MIT (with R. Jaenisch and D. Baltimore). Dr. Chun then joined the faculty at the UCSD School of Medicine, where he became Professor of Pharmacology and Neurosciences and directed the Neurosciences Graduate Program. He subsequently became Department Head of Molecular Neuroscience at Merck Research Laboratories before returning to academia as Professor at The Scripps Research Institute and adjunct Professor at UCSD, before his current position. He has made important contributions to our understanding of the brain and its diseases. His lab identified genomic mosaicism and somatic gene recombination within the brain and its involvement in the most common forms of Alzheimer’s disease, with relevance to other brain diseases. In separate work, his lab also identified the first lysophospholipid receptor, an initial member of a growing family of lipid receptors that includes S1P receptors that are targets for two current neuroscience medicines (fingolimod & siponimod for Multiple Sclerosis) with lysophospholipid receptors also linked to other diseases, including hydrocephalus, schizophrenia, neuropathic pain and fibrosis. Dr. Chun has authored more than 300 scientific publications, has been recognized in Thomson Reuters’ World’s Most Influential Scientific Minds citation list, and is a member of numerous advisory, review, and editorial boards in both academia and industry.